Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
769.33-
QQQ
716.250.03%
BTC/USD
78031.000.2594%
DIA
535.550.09%
GLD
409.230.08%
TLT
82.940.07%

Bausch Health Companies Inc

BHCNYSE
Trade with Public
Trade with Public
$6.32
0.020.32%
At close: Aug 28, 5:00 PM EST
$6.32
N/A
After Hours: Aug 28, 4:00 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Bausch Health Companies Analyst Price Targets

Wall Street analyst price targets and consensus rating for Bausch Health Companies (BHC).

Price Target Range — 10 Quarters

Analyst Consensus — 5 Analysts

4Hold
1Sell
Consensus RatingHold# Analysts5Avg. Consensus PT$7Upside to Avg. PT+13.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Apr 27, 2026RBC CapitalDouglas MiehmPT CutSector Perform$10→$9
Feb 25, 2026BarclaysGlen SantangeloPT CutEqual-Weight$8→$7
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
RBC Capital Maintains Sector Perform on Bausch Health Companies, Lowers Price Target to $9

RBC Capital analyst Douglas Miehm maintains Bausch Health Companies (NYSE:BHC) with a Sector Perform and lowers the price target from $10 to $9.
Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on Bausch Health Companies, Lowers Price Target to $7

Barclays analyst Glen Santangelo maintains Bausch Health Companies (NYSE:BHC) with a Equal-Weight and lowers the price target from $8 to $7.
Benzinga Newsdesk

PRO
Truist Securities Maintains Hold on Bausch Health Companies, Raises Price Target to $8

Truist Securities analyst Les Sulewski maintains Bausch Health Companies (NYSE:BHC) with a Hold and raises the price target from $7 to $8.
Benzinga Newsdesk

PRO
Barclays Initiates Coverage On Bausch Health Companies with Equal-Weight Rating, Announces Price Target of $8

Barclays analyst Glen Santangelo initiates coverage on Bausch Health Companies (NYSE:BHC) with a Equal-Weight rating and announces Price Target of $8.
Benzinga Newsdesk

PRO
RBC Capital Maintains Sector Perform on Bausch Health Companies, Raises Price Target to $10

RBC Capital analyst Douglas Miehm maintains Bausch Health Companies (NYSE:BHC) with a Sector Perform and raises the price target from $8.5 to $10.
Benzinga Newsdesk

PRO
Jefferies Downgrades Bausch Health Companies to Hold, Lowers Price Target to $8

Jefferies analyst David Steinberg downgrades Bausch Health Companies (NYSE:BHC) from Buy to Hold and lowers the price target from $12 to $8.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved